Noze's DiagNoze® Breathalyzer Lands $5M from Gates Foundation!
Noze, the innovative Canadian breath-based diagnostics company, has received a hefty $5 million equity investment from the Bill & Melinda Gates Foundation for its groundbreaking handheld device, DiagNoze®. This marks a significant milestone as the foundation's first equity investment in Canada, highlighting DiagNoze®'s potential to revolutionize diagnostics in low and middle-income countries by offering a non-invasive, portable, and cost-effective solution for detecting diseases like tuberculosis.
Dec 27